Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors

British Journal of Nutrition

Volumn 106, Issue 9, 2011, Pages 1416-1422

  Broekhuizen, Lysette N ^a   Van Wijk, Diederik F ^a   Vink, Hans ^b   Stalmach, A ^c   Crozier, A ^c   Hutten, B A ^a   Kastelein, John J P ^a   Hugenholtz, Paul G ^d   Koenig, Wolfgang ^e   Stroes, Erik S G ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cardiometabolic risk factors; Flow mediated dilation; Inflammation; Monocyte chemoattractant protein 1; Polyphenols

Indexed keywords

ADIPONECTIN; APPLE EXTRACT; C REACTIVE PROTEIN; GLUCOSE; GRAPE EXTRACT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; PLANT EXTRACT; POLYPHENOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLISM; MORNING DOSAGE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SHORT COURSE THERAPY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; IMMUNITY; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; METABOLIC SYNDROME X; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; POLYPHENOLS; RISK FACTORS;

EID: 80055026230     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511002431     Document Type: Article

References (54)

1. Libby P (2002) Atherosclerosis: the new view. Sci Am 286, 46-55.
2. Koenig W, Khuseyinova N, Baumert J, et al. (2006) Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol 26, 2745-2751.
3. Herder C, Baumert J, Thorand B, et al. (2006) Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol 26, 2147-2152. (Pubitemid 44253801)
4. Tuomisto K, Jousilahti P, Sundvall J, et al. (2006) C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost 95, 511-518.
5. Blake GJ & Ridker PM (2003) C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41, 4 Suppl. S, 37S-42S. (Pubitemid 36223345)
6. Hlawaty H, Jacob MP, Louedec L, et al. (2009) Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis. Arterioscler Thromb Vasc Biol 29, 518-524.
7. Ferrante AW Jr (2007) Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 262, 408-414. (Pubitemid 47404372)
8. Conen D, Rexrode KM, Creager MA, et al. (2009) Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women. A prospective study. Circulation 120, 1041-1047.
9. Rutter MK, Meigs JB, Sullivan LM, et al. (2004) C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110, 380-385. (Pubitemid 38993845)
10. Wellen KE & Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112, 1785-1788. (Pubitemid 38063699)
11. Gustafson B, Hammarstedt A, Andersson CX, et al. (2007) Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27, 2276-2283. (Pubitemid 350203940)
12. Kamei N, Tobe K, Suzuki R, et al. (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281, 26602-26614. (Pubitemid 44401869)
13. Youn HS, Lee JY, Fitzgerald KA, et al. (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175, 3339-3346. (Pubitemid 41170555)
14. Kang OH, Jang HJ, Chae HS, et al. (2009) Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. Pharmacol Res 59, 330-337.
15. Do GM, Kwon EY, Kim HJ, et al. (2008) Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem Biophys Res Commun 374, 55-59.
16. Wang Z, Zou J, Cao K, et al. (2005) Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med 16, 533-540.
17. Fuhrman B, Volkova N, Coleman R, et al. (2005) Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macro-phage atherogenicity. J Nutr 135, 722-728. (Pubitemid 40464094)
18. Perez-Jimenez J & Saura-Calixto F (2008) Grape products and cardiovascular disease risk factors. Nutr Res Rev 21, 158-173.
19. Dell'Agli M, Busciala A & Bosisio E (2004) Vascular effects of wine polyphenols. Cardiovasc Res 63, 593-602. (Pubitemid 39078672)
20. Leifert WR & Abeywardena MY (2008) Cardioprotective actions of grape polyphenols. Nutr Res 28, 729-737.
21. Desch S, Schmidt J, Kobler D, et al. (2010) Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens 23, 97-103.
22. Davidson MH, Maki KC, Dicklin MR, et al. (2009) Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol 104, 936-942.
23. Aviram M, Rosenblat M, Gaitini D, et al. (2004) Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23, 423-433. (Pubitemid 38811681)
24. Basu A, Du M, Sanchez K, et al. (2011) Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27, 206-213.
25. Basu A, Du M, Leyva MJ, et al. (2010) Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr 140, 1582-1587.
26. Jimenez JP, Serrano J, Tabernero M, et al. (2008) Effects of grape antioxidant dietary fiber in cardiovascular disease risk factors. Nutrition 24, 646-653.
27. Grundy SM, Brewer HB Jr, Cleeman JI, et al. (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438. (Pubitemid 38133916)
28. Birjmohun RS, van Leuven SI, Levels JH, et al. (2007) High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arterioscler Thromb Vasc Biol 27, 1153-1158. (Pubitemid 46641971)
29. Nieuwdorp M, van Haeften TW, Gouverneur MC, et al. (2006) Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55, 480-486. (Pubitemid 43343279)
30. Olszyna DP, De JE, Dekkers PE, et al. (2001) Induction of cell-associated chemokines after endotoxin administration to healthy humans. Infect Immun 69, 2736-2738. (Pubitemid 32239753)
31. Estruch R, Sacanella E, Badia E, et al. (2004) Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175, 117-123. (Pubitemid 38746918)
32. Arts IC & Hollman PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81, 1 Suppl., 317S-325S.
33. Sies H, Schewe T, Heiss C, et al. (2005) Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr 81, 1 Suppl., 304S-312S.
34. Vita JA (2005) Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 81, 1 Suppl., 292S-297S.
35. Oak MH, El BJ & Schini-Kerth VB (2005) Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 16, 1-8. (Pubitemid 40052710)
36. Nestel P (2003) Isoflavones: their effects on cardiovascular risk and functions. Curr Opin Lipidol 14, 3-8. (Pubitemid 36183094)
37. Opie LH & Lecour S (2007) The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 28, 1683-1693. (Pubitemid 47227092)
38. Stoclet JC, Chataigneau T, Ndiaye M, et al. (2004) Vascular protection by dietary polyphenols. Eur J Pharmacol 500, 299-313. (Pubitemid 39304017)
39. Erridge C, Attina T, Spickett CM, et al. (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286-1292. (Pubitemid 350126229)
40. DeFuria J, Bennett G, Strissel KJ, et al. (2009) Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J Nutr 139, 1510-1516.
41. Feng AN, Chen YL, Chen YT, et al. (1999) Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-fed rabbits. Circulation 100, 2254-2259.
42. Manna SK, Mukhopadhyay A & Aggarwal BB (2000) Resver-atrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164, 6509-6519. (Pubitemid 30408836)
43. Blanco-Colio LM, Munoz-Garcia B, Martin-Ventura JL, et al. (2007) Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet. Atherosclerosis 192, 335-341. (Pubitemid 46726336)
44. McDermott DH, Yang Q, Kathiresan S, et al. (2005) CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 112, 1113-1120. (Pubitemid 41216117)
45. Boring L, Gosling J, Cleary M, et al. (1998) Decreased lesion formation in CCR22/2 mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897. (Pubitemid 28410911)
46. Gu L, Okada Y, Clinton SK, et al. (1998) Absence of mono-cyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2, 275-281. (Pubitemid 128373654)
47. Verschuren L, Kooistra T, Bernhagen J, et al. (2009) MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res 105, 99-107.
48. Chen L, Yang G, Zhang X, et al. (2009) Induction of MIF expression by oxidized LDL via activation of NF-kappaB in vascular smooth muscle cells. Atherosclerosis 207, 428-433.
49. Kanda H, Tateya S, Tamori Y, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494-1505.
50. Zhu J, Yong W, Wu X, et al. (2008) Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun 369, 471-477.
51. Monagas M, Khan N, Andres-Lacueva C, et al. (2009) Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide- stimulated cytokine secretion by human peripheral blood mononuclear cells. Br J Nutr 102, 201-206.
52. Miles EA, Zoubouli P & Calder PC (2005) Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition 21, 389-394. (Pubitemid 40387940)
53. Miles EA, Zoubouli P & Calder PC (2005) Effects of polyphe-nols on human Th1 and Th2 cytokine production. Clin Nutr 24, 780-784. (Pubitemid 41403634)
54. Yang CS, Sang S, Lambert JD, et al. (2008) Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res 52, Suppl. 1, S139-S151.